Lexicon Pharmaceuticals (LXRX) Institutional Ownership $0.70 +0.00 (+0.14%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$0.72 +0.02 (+3.26%) As of 09:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lexicon Pharmaceuticals (NASDAQ:LXRX)CurrentInstitutional OwnershipPercentage74.70%Number ofInstitutional Buyers(last 12 months)54TotalInstitutional Inflows(last 12 months)$49.62MNumber ofInstitutional Sellers(last 12 months)14TotalInstitutional Outflows(last 12 months)$38.12M Get LXRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexicon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LXRX Institutional Buying and Selling by Quarter Lexicon Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers137,230$63K0.0%-10.4%0.038% 5/21/2025 Acadian Asset Management LLC573,688$263K0.0%N/A0.159% 5/16/2025 Goldman Sachs Group Inc.355,152$164K0.0%-34.3%0.098% 5/16/2025 AQR Capital Management LLC1,173,225$541K0.0%N/A0.325% 5/15/2025 Nantahala Capital Management LLC460,850$212K0.0%-93.0%0.127% 5/15/2025 Siren L.L.C.3,516,214$1.62M0.1%-91.0%0.973% 5/14/2025 Ieq Capital LLC177,302$82K0.0%N/A0.049% 5/12/2025 Invesco Ltd.285,759$132K0.0%+173.5%0.079% 5/9/2025 Deutsche Bank AG94,394$43K0.0%-70.1%0.026% 5/9/2025 Charles Schwab Investment Management Inc.1,150,771$530K0.0%-3.4%0.318% Get the Latest News and Ratings for LXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexicon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/8/2025 Monaco Asset Management SAM734,148$338K0.1%N/A0.203% 5/6/2025 Pinnacle Associates Ltd.54,180$25K0.0%-96.2%0.015% 5/1/2025 CWM LLC105,504$49K0.0%+9,228.4%0.043% 4/30/2025 Cerity Partners LLC170,387$79K0.0%+76.5%0.069% 4/28/2025 Straight Path Wealth Management62,666$29K0.0%N/A0.025% 4/16/2025 Wealth Enhancement Advisory Services LLC69,207$32K0.0%N/A0.028% 4/10/2025 Hennion & Walsh Asset Management Inc.830,054$382K0.0%-3.8%0.337% 3/18/2025 California State Teachers Retirement System195,215$144K0.0%+29.9%0.079% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC353,508$261K0.0%+193.6%0.144% 2/17/2025 Woodline Partners LP229,376$169K0.0%-81.1%0.093% 2/17/2025 Tang Capital Management LLC850,268$628K0.0%+750.3%0.345% 2/17/2025 Point72 Asset Management L.P.8,988,421$6.64M0.0%+630.7%3.650% 2/17/2025 Deutsche Bank AG315,659$234K0.0%+378.0%0.128% 2/17/2025 Bank of America Corp DE136,407$101K0.0%+27.4%0.055% 2/17/2025 Bayesian Capital Management LP42,000$31K0.0%N/A0.017% 2/14/2025 Jane Street Group LLC220,264$163K0.0%+158.0%0.089% 2/14/2025 Schonfeld Strategic Advisors LLC7,558,621$5.58M0.0%+301.5%3.070% 2/14/2025 Nantahala Capital Management LLC6,604,150$4.88M0.2%+186.6%2.682% 2/14/2025 Northern Trust Corp1,308,651$966K0.0%+14.4%0.531% 2/14/2025 Boothbay Fund Management LLC480,822$355K0.0%N/A0.195% 2/14/2025 Virtus ETF Advisers LLC425,269$314K0.1%+136.3%0.173% 2/14/2025 Price T Rowe Associates Inc. MD77,502$57K0.0%-33.9%0.031% 2/14/2025 Stifel Financial Corp112,853$83K0.0%+117.0%0.046% 2/13/2025 Barclays PLC243,316$180K0.0%+25.5%0.099% 2/13/2025 Renaissance Technologies LLC51,141$38K0.0%N/A0.021% 2/13/2025 Invesco Ltd.104,494$77K0.0%+60.6%0.042% 2/13/2025 Cerity Partners LLC96,512$71K0.0%+328.7%0.039% 2/12/2025 RPO LLC44,242$33K0.0%N/A0.018% 2/12/2025 Alliancebernstein L.P.246,121$182K0.0%-9.9%0.100% 2/12/2025 Wellington Management Group LLP747,996$552K0.0%+2.1%0.304% Get Ready for Elon Musk’s BIGGEST Comeback Yet (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again.2/11/2025 Virtu Financial LLC88,982$66K0.0%N/A0.036% 2/11/2025 Teacher Retirement System of Texas65,415$48K0.0%+60.3%0.027% 2/10/2025 Swiss National Bank426,600$315K0.0%+34.4%0.173% 2/6/2025 Arizona State Retirement System62,976$47K0.0%+34.4%0.026% 2/6/2025 Charles Schwab Investment Management Inc.1,191,091$880K0.0%-16.0%0.484% 1/15/2025 Hennion & Walsh Asset Management Inc.863,255$638K0.0%+18.1%0.351% 11/19/2024 Barclays PLC193,873$304K0.0%+391.6%0.079% 11/16/2024 Geode Capital Management LLC3,523,971$5.53M0.0%+8.4%1.431% 11/15/2024 Barclays PLC193,873$304K0.0%+391.6%0.079% 11/15/2024 XTX Topco Ltd80,423$126K0.0%N/A0.033% 11/15/2024 Jane Street Group LLC85,361$134K0.0%-85.9%0.035% 11/15/2024 State Street Corp2,471,215$3.88M0.0%+6.8%1.004% 11/15/2024 Point72 Asset Management L.P.1,230,050$1.93M0.0%-70.2%0.500% 11/15/2024 Atom Investors LP77,733$122K0.0%N/A0.032% 11/14/2024 Braidwell LP801,584$1.26M0.0%-90.3%0.326% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC120,387$189K0.0%N/A0.049% 11/14/2024 BBR Partners LLC470,000$738K0.1%+74.1%0.191% 11/13/2024 BNP Paribas Financial Markets31,853$50K0.0%+71.2%0.013% 11/13/2024 FMR LLC49,867,042$78.29M0.0%+28.9%20.251% 11/12/2024 Charles Schwab Investment Management Inc.1,417,295$2.23M0.0%+4.3%0.576% 11/9/2024 Intech Investment Management LLC73,440$115K0.0%N/A0.030% 10/25/2024 Pinnacle Associates Ltd.1,730,821$2.65M0.0%+0.9%0.703% 10/25/2024 China Universal Asset Management Co. Ltd.69,527$109K0.0%+63.7%0.028% 10/23/2024 Hennion & Walsh Asset Management Inc.731,138$1.15M0.1%+34.7%0.297% 10/11/2024 Compagnie Lombard Odier SCmA100,000$157K0.0%+6.4%0.041% 10/3/2024 SG Americas Securities LLC46,090$72K0.0%+107.6%0.019% 8/20/2024 Nantahala Capital Management LLC2,304,150$3.87M0.2%N/A0.936% 8/19/2024 Point72 Asset Management L.P.4,121,191$6.92M0.0%+605.2%1.674% 8/15/2024CVI Holdings LLC20,000$34K0.0%N/A0.008% 8/15/2024 The Manufacturers Life Insurance Company49,957$84K0.0%+40.5%0.020% 8/14/2024 Great Point Partners LLC30,000$50K0.0%N/A0.012% 8/14/2024 Marshall Wace LLP1,190,448$2M0.0%+138.5%0.483% 8/9/2024 Dimensional Fund Advisors LP76,086$128K0.0%+52.3%0.031% 8/5/2024 Victory Capital Management Inc.45,341$76K0.0%+44.5%0.018% 8/5/2024 BBR Partners LLC270,000$454K0.0%+800.0%0.110% 8/1/2024 Rhumbline Advisers152,785$257K0.0%+13.3%0.062% 7/30/2024 Pinnacle Associates Ltd.1,715,831$2.88M0.0%-1.8%0.697% 7/29/2024 Principal Financial Group Inc.22,759$38K0.0%+116.1%0.009% 7/26/2024 Bank of New York Mellon Corp401,908$675K0.0%+37.6%0.163% 7/20/2024 Hennion & Walsh Asset Management Inc.542,899$912K0.0%N/A0.220% 5/20/2024 Virtu Financial LLC43,591$105K0.0%N/A0.018% 5/16/2024 BVF Inc. IL1,686,924$4.05M0.1%-93.1%0.685% 5/14/2024Boulder Hill Capital Management LP256,400$615K0.3%N/A0.104% 5/10/2024 Vanguard Group Inc.6,401,225$15.36M0.0%+7.0%2.600% 5/7/2024 SG Americas Securities LLC19,269$46K0.0%-56.0%0.008% 5/3/2024 GSA Capital Partners LLP293,333$704K0.1%-62.4%0.119% 5/1/2024 BNP Paribas Financial Markets59,378$143K0.0%+82.6%0.024% 4/29/2024 China Universal Asset Management Co. Ltd.46,930$113K0.0%+65.7%0.019% 4/26/2024 Pinnacle Associates Ltd.1,747,830$4.20M0.1%+1.0%0.710% 2/15/2024 BVF Inc. IL24,435,632$37.39M0.9%+22.2%9.977% Get Ready for Elon Musk’s BIGGEST Comeback Yet (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again.2/15/2024 Cantor Fitzgerald L. P.16,522$25K0.0%N/A0.007% 2/12/2024 RPO LLC32,000$49K0.1%N/A0.013% 2/7/2024 Principal Securities Inc.21,500$33K0.0%N/A0.009% 2/5/2024 Victory Capital Management Inc.32,187$49K0.0%+22.0%0.013% 1/24/2024 China Universal Asset Management Co. Ltd.28,329$43K0.0%+350.7%0.012% 1/19/2024 Pinnacle Associates Ltd.1,730,821$2.65M0.0%-9.5%0.707% 1/12/2024 SG Americas Securities LLC43,793$67K0.0%-25.4%0.018% 1/11/2024 KWB Wealth40,640$62K0.0%N/A0.017% 11/13/2023ClariVest Asset Management LLC192,398$210K0.0%-62.4%0.079% 11/13/2023 FMR LLC7,563,076$8.24M0.0%-11.1%3.088% (Data available from 1/1/2016 forward) LXRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LXRX shares? During the previous two years, 78 institutional investors and hedge funds held shares of Lexicon Pharmaceuticals. The most heavily invested institutionals were Artal Group S.A. ($269.20M), FMR LLC ($78.29M), Vanguard Group Inc. ($15.36M), Point72 Asset Management L.P. ($6.64M), Schonfeld Strategic Advisors LLC ($5.58M), Geode Capital Management LLC ($5.53M), and BVF Inc. IL ($4.05M).Learn more on LXRX's institutional investors. What percentage of Lexicon Pharmaceuticals stock is owned by institutional investors? 74.70% of Lexicon Pharmaceuticals stock is owned by institutional investors. Learn more on LXRX's institutional investor holdings. Which institutional investors have been buying Lexicon Pharmaceuticals stock? Of the 69 institutional investors that purchased Lexicon Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Artal Group S.A. ($27.78M), Point72 Asset Management L.P. ($11.30M), FMR LLC ($11.18M), BVF Inc. IL ($8.29M), Nantahala Capital Management LLC ($6.60M), Schonfeld Strategic Advisors LLC ($5.68M), and AQR Capital Management LLC ($1.17M). How much institutional buying is happening at Lexicon Pharmaceuticals? Institutional investors have bought a total of 82,106,211 shares in the last 24 months. This purchase volume represents approximately $132.60M in transactions. Which Lexicon Pharmaceuticals major shareholders have been selling company stock? Of the 21 institutional investors that sold Lexicon Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Siren L.L.C. ($35.40M), BVF Inc. IL ($22.75M), Braidwell LP ($7.49M), Nantahala Capital Management LLC ($6.14M), Point72 Asset Management L.P. ($2.89M), Pinnacle Associates Ltd. ($1.67M), and Woodline Partners LP ($982.55K). How much institutional selling is happening at Lexicon Pharmaceuticals? Institutional investors have sold a total of 80,643,165 shares in the last 24 months. This volume of shares sold represents approximately $96.18M in transactions. Related Companies GERN Major Shareholders RGLS Major Shareholders ZBIO Major Shareholders MYGN Major Shareholders RIGL Major Shareholders EBS Major Shareholders VSTM Major Shareholders XOMA Major Shareholders VNDA Major Shareholders CDXS Major Shareholders This page (NASDAQ:LXRX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexicon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexicon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LXRX Stock Free LXRX Stock Alerts